-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Puma Biotechnology, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q2 2024.
- Puma Biotechnology, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $378K, a 102% increase year-over-year.
- Puma Biotechnology, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $1.35M, a 93.8% increase year-over-year.
- Puma Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2023 was $1.08M, a 138% increase from 2022.
- Puma Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2022 was $455K, a 40.4% increase from 2021.
- Puma Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2021 was $324K, a 56.5% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)